These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14602890)

  • 1. Molecular mechanisms of amyloidosis.
    Sungur CI
    N Engl J Med; 2003 Nov; 349(19):1872-3; author reply 1872-3. PubMed ID: 14602890
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum amyloid A levels in kidney-transplanted patients with familial Mediterranean fever-amyloidosis.
    Kivity S; Danilesko I; Ben-Zvi I; Gilburd B; Kukuy OL; Rahamimov R; Livneh A
    Isr Med Assoc J; 2011 Apr; 13(4):202-5. PubMed ID: 21598805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of amyloidosis.
    van der Hilst JC; Simon A; Drenth JP
    N Engl J Med; 2003 Nov; 349(19):1872-3; author reply 1872-3. PubMed ID: 14606469
    [No Abstract]   [Full Text] [Related]  

  • 4. [Familial Mediterranean fever with amyloidosis. Recent pathogenetic and therapeutic aspects].
    Löffler HJ; Brass H; Thoenes W; Linke RP
    Dtsch Med Wochenschr; 1983 Feb; 108(6):210-5. PubMed ID: 6825596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum amyloid a protein concentrations in patients with familial Mediterranean fever].
    Dzhndoian ZT
    Georgian Med News; 2011 Dec; (201):48-51. PubMed ID: 22306501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amyloidosis of familial Mediterranean fever (FMF)--insights to FMF phenotype II].
    Livneh A
    Harefuah; 2006 Oct; 145(10):743-5, 782. PubMed ID: 17111710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of nephrotic syndrome due to AA-amyloidosis, complicating familiar Mediterranean fever, with tocilizumab.
    Serelis J; Christaki S; Skopouli FN
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S169. PubMed ID: 25572486
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactive amyloidosis and familial Mediterranean fever (FMF).
    Takahashi N; Suzuki E; Gejyo F
    Intern Med; 2002 May; 41(5):329-30. PubMed ID: 12058876
    [No Abstract]   [Full Text] [Related]  

  • 9. Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever.
    Yilmaz S; Cinar M; Simsek I; Erdem H; Pay S
    Rheumatology (Oxford); 2015 Mar; 54(3):564-5. PubMed ID: 25504961
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.
    van der Hilst JC; Drenth JP; Bodar EJ; Bijzet J; van der Meer JW; Simon A;
    Amyloid; 2005 Jun; 12(2):115-9. PubMed ID: 16011988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-2-microglobulin levels of dialysis patients with renal amyloidosis secondary to familial Mediterranean fever.
    Sungur C; Ozen S; Ozkuyumcu C; Akpolat T; Yasavul U; Turgan C; Caglar S
    Nephron; 1994; 68(1):152. PubMed ID: 7991035
    [No Abstract]   [Full Text] [Related]  

  • 12. Periodontal disease in patients with familial Mediterranean fever: from inflammation to amyloidosis.
    Cengiz MI; Bagci H; Cengiz S; Yigit S; Cengiz K
    J Periodontal Res; 2009 Jun; 44(3):354-61. PubMed ID: 18973533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of the familial Mediterranean fever gene: expectations for learning about the pathogenesis of amyloid A amyloidosis.
    Pras M
    Adv Nephrol Necker Hosp; 1998; 28():343-54. PubMed ID: 9889998
    [No Abstract]   [Full Text] [Related]  

  • 14. Colchicine treatment in familial Mediterranean fever: an indirect effect on in vitro serum amyloid A secretion via leukocyte derived factors.
    Barash J; Pirogovski A; Livneh A; Brezniak N; Dror Y; Hahn T
    Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S76. PubMed ID: 11760407
    [No Abstract]   [Full Text] [Related]  

  • 15. [Patient with familial Mediterranean fever and amyloidosis].
    Atanasova P
    Vutr Boles; 1985; 24(5):93-6. PubMed ID: 4090459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in familial Mediterranean fever.
    Pras M; Gafni J; Jacob ET; Cabili S; Zemer D; Sohar E
    Adv Nephrol Necker Hosp; 1984; 13():261-70. PubMed ID: 6433668
    [No Abstract]   [Full Text] [Related]  

  • 17. Macular involvement in secondary systemic amyloidosis.
    Altiparmak UE; Koklu B; Unlu N; Yagci R; Bayrak R; Gul Yilmaz Cinar F; Duman S
    Eur J Ophthalmol; 2008; 18(3):459-61. PubMed ID: 18465734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial paroxysmal polyserositis (familial Mediterranean fever); incidence of amyloidosis and mode of inheritance.
    Khachadurian AK; Armenian HK
    Birth Defects Orig Artic Ser; 1974; 10(4):62-6. PubMed ID: 4470910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of amyloid A and serum amyloid A by red blood cell haemolysate in patients with familial mediterranean fever.
    Shainkin-Kestenbaum R; Winikoff Y; Zimlichman S; Gorodischer R; Pras M
    Eur J Clin Invest; 1984 Oct; 14(5):398-401. PubMed ID: 6437839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A renal transplant recipient with delayed gastric emptying in amyloidosis due to familial Mediterranean fever improved with erythromycin: a case report.
    Saglam F; Celik A; Cavdar C; Sifil A; Atila K; Kaya GC; Bora S; Gulay H; Camsari T
    Transplant Proc; 2008; 40(1):308-9. PubMed ID: 18261613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.